TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ATRA

Atara Biotherapeutics Inc

Healthcare · Biotechnology

8.90$ +4.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Atara Biotherapeutics Inc (ATRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 21 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATRA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
189 166 165 117 143 109 62 37 30 20 20 21
119 102 106 62 92 65 27 25 18 12 12 14
65 26 35 31 46 25 14 17 5.7 8.5 8.4 3.2
102 52 46 35 67 42 14 22 14 8.5 8.4 9.9
0.2 34 36 2.4 1.3 1.5 8.9 0.0 1.9 1.3 0.0 0.3
6.6 9.7 16 19 14 11 0.0 0.0 0.0 0.0 – –
64 – – – – – – – – – – –
240 265 264 228 233 206 117 72 67 59 57 58
79 142 181 148 156 135 48 15 18 15 5.6 6.8
13 12 14 14 15 14 14 2.2 12 11 1.0 1.1
6.5 3.7 2.9 5.3 2.1 4.4 1.4 1.8 0.3 0.1 0.6 0.8
-51 -99 -98 -111 -91 -97 -55 -35 -37 -39 -37 -37
-1,909 -1,969 -2,001 -2,020 -2,042 -2,055 -2,017 -2,014 -2,018 -2,022 -2,026 -2,031
4.3 4.3 5.6 6.1 7.5 11 11 12 14 13 14 15

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?